Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Sema4 Sema4|GeneDx to Participate in the 41st Annual J.P. Morgan Healthcare Conference December 30, 2022 From Sema4 Via GlobeNewswire Tickers SMFR SMFRW New Research from Sema4|GeneDx Highlights the Importance of Rapid Exome Sequencing for Diagnosing Mitochondrial Diseases in the NICU December 05, 2022 From Sema4 Via GlobeNewswire Tickers SMFR SMFRW Sema4 Reports Third Quarter 2022 Financial Results and New Strategic Direction November 14, 2022 From Sema4 Via GlobeNewswire Tickers SMFR SMFRW Sema4 to Report Third Quarter 2022 Financial Results on Monday, November 14th, 2022 November 04, 2022 From Sema4 Via GlobeNewswire Tickers SMFR SMFRW Sema4|GeneDx Commends New Evidence-Based Guidelines from the National Society of Genetic Counselors Recommending Exome Sequencing as a First-Tier Genetic Test for Unexplained Epilepsies October 31, 2022 From Sema4 Via GlobeNewswire Tickers SMFR SMFRW Sema4|GeneDx Announces Results from Phase 1 of SeqFirst Study, Demonstrating Broad Utility of Rapid Whole Genome Sequencing for Critically Ill Newborns October 27, 2022 From Sema4 Via GlobeNewswire Tickers SMFR SMFRW Sema4|GeneDx collaborates on new research demonstrating genome and exome sequencing deliver more diagnostic certainty than multi-gene panels October 26, 2022 From Sema4 Via GlobeNewswire Tickers SMFR SMFRW Study Demonstrates the Utility of Exome Sequencing for Diagnosing Autism Spectrum Disorders October 13, 2022 From Sema4 Via GlobeNewswire Tickers SMFR SMFRW Sema4|GeneDx To Provide Whole Genome Sequencing and Interpretation Services for Landmark Genomic Newborn Screening Study October 05, 2022 From Sema4 Via GlobeNewswire Tickers SMFR SMFRW Sema4 to Report Second Quarter 2022 Financial Results on Monday, August 15, 2022 July 26, 2022 From Sema4 Via GlobeNewswire Tickers SMFR SMFRW Former Magenta Therapeutics and Foundation Medicine CFO Jason Ryan to Join Sema4 Board of Directors July 07, 2021 From Sema4 Via Business Wire Sema4 Appoints Andrew Kasarskis, Health Data Expert and Precision Medicine Scientist, as Chief Data Officer June 17, 2021 From Sema4 Via Business Wire Sema4 and CM Life Sciences Announce the Filing of Amended Preliminary Proxy Statement June 10, 2021 From Sema4 Via Business Wire AdventHealth and Sema4 Launch a Data-driven Precision Medicine Program to Optimize Patient Care and Outcomes May 25, 2021 From Sema4 Via Business Wire Sema4 to Participate in Upcoming Investor Conferences May 24, 2021 From Sema4 Via Business Wire Sema4 and CM Life Sciences Announce the Filing of the Schedule-14A Proxy Statement in Connection with the Proposed Merger May 06, 2021 From Sema4 Via Business Wire NorthShore and Sema4 Launch System-Wide Genomics Program to Improve Primary and Specialty Care with Data-Driven Insights April 19, 2021 From Sema4 Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.